Live
Home·Deals·pharmaceuticals·Sun Pharma acquires Organon
Sun Pharma acquires Organon (2026)
SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-11
acquisitionAnnounced · Apr 27, 2026pharmaceuticalsSource · CredibleArticle · Factual
Organon
Sun Pharma
Organon · Sun Pharma

Sun Pharma acquires Organon

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$10B
Target
Organon
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Sun Pharma
Full Acquisition
Status
Pending

Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.

This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.

Sun Pharma Signs Definitive Agreement to Acquire Organon On Apr 27, 2026 Sun Pharma has entered into a definitive agreement with Jersey City -based Organon , to acquire all of the latter company outstanding shares for $14 per share in an all‑cash transaction valued at $11.75 billion

Deal timeline

Announced
Apr 27, 2026 · njbmagazine.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.

Sources: njbmagazine.com · Primary article · FireStrike proprietary index